Secondary Logo

Institutional members access full text with Ovid®

CORR Insights®

Soft Tissue Sarcoma of the Extremities

What Is the Value of Treating at High-volume Centers?

Ghert, Michelle, MD, FRCSC

Clinical Orthopaedics and Related Research®: April 2019 - Volume 477 - Issue 4 - p 728–729
doi: 10.1097/CORR.0000000000000344
2017 MUSCULOSKELETAL TUMOR SOCIETY PROCEEDINGS
Buy

M. Ghert, Associate Professor, McMaster University and Hamilton Health Sciences, Department of Surgery, Hamilton, Ontario, Canada

Michelle Ghert MD, FRCSC, McMaster University and Hamilton Health Sciences, Department of Surgery, 711 Concession Street, Hamilton, Ontario L8V 1C3 Canada, Email: ghertm@mcmaster.ca

This CORR Insights® is a commentary on the article “Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?” by Lazarides and colleagues available at: DOI: 10.1007/s11999.0000000000000307.

The author certifies that neither she, nor any members of her immediate family, have any commercial associations (such as consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

This CORR Insights® comment refers to the article available at DOI: 10.1007/s11999.0000000000000307.

Received April 18, 2018

Accepted April 23, 2018

© 2019 Lippincott Williams & Wilkins LWW
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website